Evaluation of HP 029 (Velnacrine Maleate) in Alzheimer's Diseasea (Q33296510)

25 July 2017

title

Evaluation of HP 029 (velnacrine maleate) in Alzheimer's disease (English)

1 reference

25 July 2017

Evaluation of HP 029 (Velnacrine Maleate) in Alzheimer's Diseasea (English)

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00229.X

history and philosophy of science

21 November 2022

main subject

Alzheimer's disease

0 references

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00229.X

21 November 2022

author name string

M. F. Murphy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1776747

21 November 2022

S. T. Hardiman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1776747

21 November 2022

R. J. Nash

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1776747

21 November 2022

F. J. Huff

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1776747

21 November 2022

J. J. Demkovich

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1776747

21 November 2022

C. Dobson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1776747

21 November 2022

U. E. Knappe

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1776747

21 November 2022

language of work or name

English

0 references

publication date

1 January 1991

1 reference

full work available at URL

25 July 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1749-6632.1991.tb00229.x

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00229.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1749-6632.1991.tb00229.x/fullpdf

21 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00229.X

Annals of the New York Academy of Sciences

21 November 2022

published in

1 reference

25 July 2017

volume

640

1 reference

25 July 2017

page(s)

253-262

1 reference

Heterogeneity of adverse hepatic reactions to tetrahydroaminoacridine

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00229.X

Age-specific norms for the Mini-Mental State Exam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00229.X

The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00229.X

Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00229.X

Clinical safety, tolerance, and plasma levels of the oral anticholinesterase 1,2,3,4-tetrahydro-9-aminoacridin-1-oL-maleate (HP 029) in Alzheimer's disease: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00229.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00229.X

Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00229.X

Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00229.X

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00229.X

A Multiple Testing Procedure for Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00229.X

Single dose safety, tolerance, and pharmacokinetics of HP 029 in healthy young men: a potential Alzheimer agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00229.X

Multiple dose pharmacokinetics, safety, and tolerance of velnacrine (HP 029) in healthy elderly subjects: a potential therapeutic agent for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00229.X

A new rating scale for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00229.X

Pathological verification of ischemic score in differentiation of dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00229.X

9-Amino-1,2,3,4-tetrahydroacridin-1-ols: synthesis and evaluation as potential Alzheimer's disease therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00229.X

Effect of scopolamine and HP 029, a cholinesterase inhibitor, on long-term potentiation in hippocampal slices of the guinea pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00229.X

The Global Deterioration Scale for assessment of primary degenerative dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00229.X

Drug-induced hepatotoxicity

21 January 2018

10

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00229.X

Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living

21 November 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00229.X

Tacrine in the treatment of Alzheimer's disease. A clinical update and recent pharmacologic studies

21 November 2022

22

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00229.X

21 November 2022

Identifiers

1 reference

25 July 2017

1 reference